Alexander C. Huang

19.2k total citations · 4 hit papers
42 papers, 4.0k citations indexed

About

Alexander C. Huang is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Alexander C. Huang has authored 42 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 24 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Alexander C. Huang's work include Cancer Immunotherapy and Biomarkers (21 papers), Immunotherapy and Immune Responses (18 papers) and CAR-T cell therapy research (12 papers). Alexander C. Huang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (21 papers), Immunotherapy and Immune Responses (18 papers) and CAR-T cell therapy research (12 papers). Alexander C. Huang collaborates with scholars based in United States, Netherlands and Australia. Alexander C. Huang's co-authors include Roberta Zappasodi, E. John Wherry, Sasikanth Manne, Omar Khan, Ravi K. Amaravadi, Lynn M. Schuchter, Kristen E. Pauken, Makoto Kurachi, Tara C. Mitchell and Bertram Bengsch and has published in prestigious journals such as Science, Cell and Journal of Clinical Investigation.

In The Last Decade

Alexander C. Huang

38 papers receiving 3.9k citations

Hit Papers

Epigenetic stability of e... 2016 2026 2019 2022 2016 2016 2020 2022 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander C. Huang United States 19 2.6k 2.5k 951 326 271 42 4.0k
Álvaro Teijeira Spain 33 2.2k 0.8× 2.4k 0.9× 937 1.0× 315 1.0× 294 1.1× 74 3.9k
Justin Kline United States 33 2.8k 1.1× 3.6k 1.4× 1.2k 1.2× 248 0.8× 247 0.9× 146 5.5k
Pia Kvistborg Netherlands 22 2.2k 0.8× 2.1k 0.8× 926 1.0× 249 0.8× 249 0.9× 50 3.1k
Marka R. Crittenden United States 37 2.8k 1.1× 2.4k 0.9× 719 0.8× 583 1.8× 254 0.9× 106 4.0k
Harry Dolstra Netherlands 42 2.4k 0.9× 3.3k 1.3× 1.1k 1.2× 155 0.5× 194 0.7× 123 5.2k
Andreas Wieland United States 25 2.1k 0.8× 2.4k 0.9× 671 0.7× 288 0.9× 253 0.9× 48 3.6k
Andrea Schietinger United States 25 3.1k 1.2× 3.5k 1.4× 1.2k 1.3× 305 0.9× 336 1.2× 41 5.1k
Jon M. Wigginton United States 32 2.1k 0.8× 2.0k 0.8× 823 0.9× 376 1.2× 290 1.1× 100 3.5k
Antonella Sistigu Italy 24 1.6k 0.6× 1.5k 0.6× 825 0.9× 316 1.0× 276 1.0× 38 2.9k
Mark P. Rubinstein United States 32 2.1k 0.8× 3.4k 1.4× 817 0.9× 177 0.5× 339 1.3× 76 4.6k

Countries citing papers authored by Alexander C. Huang

Since Specialization
Citations

This map shows the geographic impact of Alexander C. Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander C. Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander C. Huang more than expected).

Fields of papers citing papers by Alexander C. Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander C. Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander C. Huang. The network helps show where Alexander C. Huang may publish in the future.

Co-authorship network of co-authors of Alexander C. Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander C. Huang. A scholar is included among the top collaborators of Alexander C. Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander C. Huang. Alexander C. Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miura, John T., Mohammad Saad Farooq, Phyllis A. Gimotty, et al.. (2025). Neoadjuvant-adjuvant pembrolizumab in clinical stage IIB/C melanoma.. Journal of Clinical Oncology. 43(16_suppl). 9502–9502. 1 indexed citations
2.
Huang, Alexander C., Xiaowei Xu, Rosemarie Mick, et al.. (2024). FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma. Clinical Cancer Research. 30(9). 1758–1767. 10 indexed citations
3.
Mitchell, Tara C., David E. Elder, Phyllis A. Gimotty, et al.. (2024). Tumor-Infiltrating Lymphocytes in Necrotic Tumors after Melanoma Neoadjuvant Anti–PD-1 Therapy Correlate with Pathologic Response and Recurrence-Free Survival. Clinical Cancer Research. 30(21). 4987–4994. 1 indexed citations
4.
Ngiow, Shin Foong, Sasikanth Manne, Yinghui Huang, et al.. (2024). LAG-3 sustains TOX expression and regulates the CD94/NKG2-Qa-1b axis to govern exhausted CD8 T cell NK receptor expression and cytotoxicity. Cell. 187(16). 4336–4354.e19. 47 indexed citations
5.
Kim, Justin, David Qualls, Madeline A. Hwee, et al.. (2022). Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses. Cancer Cell. 40(7). 738–753.e5. 32 indexed citations
7.
Giles, Josephine R., Shin Foong Ngiow, Sasikanth Manne, et al.. (2022). Shared and distinct biological circuits in effector, memory and exhausted CD8+ T cells revealed by temporal single-cell transcriptomics and epigenetics. Nature Immunology. 23(11). 1600–1613. 119 indexed citations
8.
Ou, Lingling, Huaishan Wang, Hui Huang, et al.. (2022). Preclinical platforms to study therapeutic efficacy of human γδ T cells. Clinical and Translational Medicine. 12(6). e814–e814. 28 indexed citations
9.
McLane, Laura M., Shin Foong Ngiow, Zeyu Chen, et al.. (2021). Role of nuclear localization in the regulation and function of T-bet and Eomes in exhausted CD8 T cells. Cell Reports. 35(6). 109120–109120. 77 indexed citations
10.
Sun, Lova, Anh N. Le, Abigail Doucette, et al.. (2020). Rates of COVID-19–Related Outcomes in Cancer Compared With Noncancer Patients. JNCI Cancer Spectrum. 5(1). 27 indexed citations
11.
Mohiuddin, Jahan J., Brian Chu, Andrea Facciabene, et al.. (2020). Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving Immunotherapy. JNCI Journal of the National Cancer Institute. 113(2). 162–170. 96 indexed citations
12.
Muroyama, Yuki, Goh Tanaka, Alexander C. Huang, et al.. (2020). Alpha-Fetoprotein-Producing Lung Hepatoid Adenocarcinoma with Brain Metastasis Treated with S-1. Case Reports in Oncology. 13(3). 1552–1559. 10 indexed citations
13.
Huang, Alexander C., Giorgos C. Karakousis, Wei Xu, et al.. (2020). Landmark analysis of immunotherapy duration and disease free survival in advanced melanoma patients with a complete response.. Journal of Clinical Oncology. 38(15_suppl). 10054–10054. 2 indexed citations
14.
Beltra, Jean‐Christophe, Sasikanth Manne, Mohamed S. Abdel-Hakeem, et al.. (2020). Developmental relationships of four exhausted CD8 T cell subsets reveals underlying transcriptional and epigenetic control mechanisms. The Journal of Immunology. 204(1_Supplement). 77.16–77.16. 2 indexed citations
15.
Zappasodi, Roberta, Sadna Budhu, Matthew D. Hellmann, et al.. (2018). Non-conventional Inhibitory CD4+Foxp3−PD-1hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity. Cancer Cell. 33(6). 1017–1032.e7. 113 indexed citations
16.
Bengsch, Bertram, Takuya Ohtani, Omar Khan, et al.. (2018). Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells. Immunity. 48(5). 1029–1045.e5. 183 indexed citations
17.
Serrano, Leona, Harpal S. Sandhu, Katherine E. Uyhazi, et al.. (2018). FREQUENT SUBCLINICAL MACULAR CHANGES IN COMBINED BRAF/MEK INHIBITION WITH HIGH-DOSE HYDROXYCHLOROQUINE AS TREATMENT FOR ADVANCED METASTATIC BRAF MUTANT MELANOMA. Retina. 39(3). 502–513. 22 indexed citations
18.
Pauken, Kristen E., Morgan A. Sammons, Pamela M. Odorizzi, et al.. (2016). Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Science. 354(6316). 1160–1165. 900 indexed citations breakdown →
19.
Benci, Joseph L., Bihui Xu, Yu Qiu, et al.. (2016). Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade. Cell. 167(6). 1540–1554.e12. 804 indexed citations breakdown →
20.
Carreno, Beatriz M., Michelle Becker‐Hapak, Alexander C. Huang, et al.. (2013). IL-12p70–producing patient DC vaccine elicits Tc1-polarized immunity. Journal of Clinical Investigation. 123(8). 3383–3394. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026